利妥昔单抗治疗非霍奇金淋巴瘤后发生的进行性多灶性白质脑病 - Suppr

Suppr

超能文献

Progressive multifocal leukoencephalopathy after rituximab in a case of non-Hodgkin lymphoma.

作者信息

Kranick Sarah M, Mowry Ellen M, Rosenfeld Myrna R

机构信息

Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Neurology. 2007 Aug 14;69(7):704-6. doi: 10.1212/01.wnl.0000267325.06000.d9.

DOI:10.1212/01.wnl.0000267325.06000.d9

PMID:17698796

Abstract

摘要

相似文献

Progressive multifocal leukoencephalopathy after rituximab in a case of non-Hodgkin lymphoma.

Neurology. 2007 Aug 14;69(7):704-6. doi: 10.1212/01.wnl.0000267325.06000.d9.

Progressive multifocal leukoencephalopathy: a report of three cases in HIV-negative patients with non-Hodgkin's lymphomas treated with rituximab.

Ann Hematol. 2010 May;89(5):519-22. doi: 10.1007/s00277-009-0819-2. Epub 2009 Aug 29.

Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis.

Arthritis Rheum. 2009 Nov;60(11):3225-8. doi: 10.1002/art.24906.

Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.

Arch Neurol. 2009 Aug;66(8):1016-20. doi: 10.1001/archneurol.2009.157.

[Progressive multifocal leukoencephalopathy after natalizumab therapy].

Med Sci (Paris). 2005 Oct;21(10):797-8. doi: 10.1051/medsci/20052110797.

Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab.

J Clin Virol. 2010 Aug;48(4):291-3. doi: 10.1016/j.jcv.2010.05.003. Epub 2010 Jun 16.

Alpha-interferon therapy in a case of probable progressive multifocal leukoencephalopathy.

Acta Neurol Belg. 1992;92(1):24-9.

Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab.

Transplantation. 2003 Jul 27;76(2):435-6. doi: 10.1097/01.TP.0000078897.11633.5F.

Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis.

N Engl J Med. 2005 Oct 20;353(16):1744-6; author reply 1744-6. doi: 10.1056/NEJMc052311.

Rituximab in relapsing-remitting multiple sclerosis.

N Engl J Med. 2008 Jun 12;358(24):2645; author reply 2646-7.

引用本文的文献

Clinical Response and Pattern of B cell Suppression with Single Low Dose Rituximab in Nephrology.

Kidney360. 2020 Apr 2;1(5):359-367. doi: 10.34067/KID.0000072020. eCollection 2020 May 28.

Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.

J Neurol. 2016 Oct;263(10):2004-21. doi: 10.1007/s00415-016-8217-x. Epub 2016 Jul 11.

Inhibition of large T antigen ATPase activity as a potential strategy to develop anti-polyomavirus JC drugs.

Antiviral Res. 2014 Dec;112:113-9. doi: 10.1016/j.antiviral.2014.10.004. Epub 2014 Oct 15.

B cells as under-appreciated mediators of non-auto-immune inflammatory disease.

Cytokine. 2010 Jun;50(3):234-42. doi: 10.1016/j.cyto.2010.02.022. Epub 2010 Apr 10.

Promising treatments of tomorrow for multiple sclerosis.

Ann Indian Acad Neurol. 2009 Oct;12(4):283-90. doi: 10.4103/0972-2327.58279.

Review of teriflunomide and its potential in the treatment of multiple sclerosis.

Neuropsychiatr Dis Treat. 2009;5:333-40. Epub 2009 Jun 10.

[Progressive multifocal leukoencephalopathy. Undesirable side effect of immunotherapy].

Nervenarzt. 2009 Oct;80(10):1143-4, 1146-8, 1150-3. doi: 10.1007/s00115-009-2701-9.

Rituximab therapy for membranous nephropathy: a systematic review.

Clin J Am Soc Nephrol. 2009 Apr;4(4):734-44. doi: 10.2215/CJN.05231008. Epub 2009 Mar 11.

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.

Blood. 2009 May 14;113(20):4834-40. doi: 10.1182/blood-2008-10-186999. Epub 2009 Mar 5.

[Targeting B cells in multiple sclerosis. Current concepts and strategies].

Nervenarzt. 2009 Feb;80(2):190-8. doi: 10.1007/s00115-008-2664-2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Progressive multifocal leukoencephalopathy after rituximab in a case of non-Hodgkin lymphoma.

作者信息

Kranick Sarah M, Mowry Ellen M, Rosenfeld Myrna R

机构信息

Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Neurology. 2007 Aug 14;69(7):704-6. doi: 10.1212/01.wnl.0000267325.06000.d9.

DOI:10.1212/01.wnl.0000267325.06000.d9

PMID:17698796

Abstract

摘要

相似文献

Progressive multifocal leukoencephalopathy after rituximab in a case of non-Hodgkin lymphoma.

Neurology. 2007 Aug 14;69(7):704-6. doi: 10.1212/01.wnl.0000267325.06000.d9.

Progressive multifocal leukoencephalopathy: a report of three cases in HIV-negative patients with non-Hodgkin's lymphomas treated with rituximab.

Ann Hematol. 2010 May;89(5):519-22. doi: 10.1007/s00277-009-0819-2. Epub 2009 Aug 29.

Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis.

Arthritis Rheum. 2009 Nov;60(11):3225-8. doi: 10.1002/art.24906.

Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.

Arch Neurol. 2009 Aug;66(8):1016-20. doi: 10.1001/archneurol.2009.157.

[Progressive multifocal leukoencephalopathy after natalizumab therapy].

Med Sci (Paris). 2005 Oct;21(10):797-8. doi: 10.1051/medsci/20052110797.

Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab.

J Clin Virol. 2010 Aug;48(4):291-3. doi: 10.1016/j.jcv.2010.05.003. Epub 2010 Jun 16.

Alpha-interferon therapy in a case of probable progressive multifocal leukoencephalopathy.

Acta Neurol Belg. 1992;92(1):24-9.

Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab.

Transplantation. 2003 Jul 27;76(2):435-6. doi: 10.1097/01.TP.0000078897.11633.5F.

Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis.

N Engl J Med. 2005 Oct 20;353(16):1744-6; author reply 1744-6. doi: 10.1056/NEJMc052311.

Rituximab in relapsing-remitting multiple sclerosis.

N Engl J Med. 2008 Jun 12;358(24):2645; author reply 2646-7.

引用本文的文献

Clinical Response and Pattern of B cell Suppression with Single Low Dose Rituximab in Nephrology.

Kidney360. 2020 Apr 2;1(5):359-367. doi: 10.34067/KID.0000072020. eCollection 2020 May 28.

Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.

J Neurol. 2016 Oct;263(10):2004-21. doi: 10.1007/s00415-016-8217-x. Epub 2016 Jul 11.

Inhibition of large T antigen ATPase activity as a potential strategy to develop anti-polyomavirus JC drugs.

Antiviral Res. 2014 Dec;112:113-9. doi: 10.1016/j.antiviral.2014.10.004. Epub 2014 Oct 15.

B cells as under-appreciated mediators of non-auto-immune inflammatory disease.

Cytokine. 2010 Jun;50(3):234-42. doi: 10.1016/j.cyto.2010.02.022. Epub 2010 Apr 10.

Promising treatments of tomorrow for multiple sclerosis.

Ann Indian Acad Neurol. 2009 Oct;12(4):283-90. doi: 10.4103/0972-2327.58279.

Review of teriflunomide and its potential in the treatment of multiple sclerosis.

Neuropsychiatr Dis Treat. 2009;5:333-40. Epub 2009 Jun 10.

[Progressive multifocal leukoencephalopathy. Undesirable side effect of immunotherapy].

Nervenarzt. 2009 Oct;80(10):1143-4, 1146-8, 1150-3. doi: 10.1007/s00115-009-2701-9.

Rituximab therapy for membranous nephropathy: a systematic review.

Clin J Am Soc Nephrol. 2009 Apr;4(4):734-44. doi: 10.2215/CJN.05231008. Epub 2009 Mar 11.

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.

Blood. 2009 May 14;113(20):4834-40. doi: 10.1182/blood-2008-10-186999. Epub 2009 Mar 5.

[Targeting B cells in multiple sclerosis. Current concepts and strategies].

Nervenarzt. 2009 Feb;80(2):190-8. doi: 10.1007/s00115-008-2664-2.